These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 22845427)

  • 101. Patients with acute coronary syndrome and nonobstructive coronary artery disease in the real world are markedly undertreated.
    De Ferrari GM; Leonardi S; Baduena L; Chieffo E; Lesce A; Repetto A; Previtali M
    J Cardiovasc Med (Hagerstown); 2011 Oct; 12(10):700-8. PubMed ID: 21738050
    [TBL] [Abstract][Full Text] [Related]  

  • 102. [Impact of different intervention models on adherence to secondary prevention therapies in patients with acute coronary syndrome].
    Liu J; Wang W; Liu J; Wang Y; Qi Y; Sun JY; Zhao D
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):124-130. PubMed ID: 29495236
    [No Abstract]   [Full Text] [Related]  

  • 103. Target Doses of Secondary Prevention Medications Are Not Being Achieved in Patients With Reduced Left Ventricular Ejection Fraction After Acute Coronary Syndrome (ANZACS-QI 34).
    Chan D; Doughty RN; Lund M; Lee M; Kerr AJ
    Heart Lung Circ; 2020 Sep; 29(9):1386-1396. PubMed ID: 32423781
    [TBL] [Abstract][Full Text] [Related]  

  • 104. [SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS].
    Yahia DH; Pereg D; Lishner M; Elis A
    Harefuah; 2015 May; 154(5):299-302, 339-40. PubMed ID: 26168639
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Treatment outcome of acute coronary syndrome patients admitted to Ayder Comprehensive Specialized Hospital, Mekelle, Ethiopia; A retrospective cross-sectional study.
    Desta DM; Nedi T; Hailu A; Atey TM; Tsadik AG; Asgedom SW; Kasahun GG; Ayalew E
    PLoS One; 2020; 15(2):e0228953. PubMed ID: 32053702
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The impact of age and chronic kidney disease on secondary prevention post-primary percutaneous coronary intervention.
    Zachariah D; Brown R; Kanagala P; Bashir A; Mohan M; Callan P; Rajendra R; Clark AL; Squire I; Gunning M; Lang CC; Kalra PR
    QJM; 2014 Mar; 107(3):185-92. PubMed ID: 24194563
    [TBL] [Abstract][Full Text] [Related]  

  • 107. A decade of improvement in the management of New Zealand ST-elevation myocardial infarction (STEMI) patients: results from the New Zealand Acute Coronary Syndrome (ACS) Audit Group national audits of 2002, 2007 and 2012.
    Elliott JM; Wang TK; Gamble GD; Williams MJ; Matsis P; Troughton R; Hamer A; Devlin G; Mann S; Richards M; French JK; White HD; Ellis CJ
    N Z Med J; 2017 Apr; 130(1453):17-28. PubMed ID: 28384143
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Long-term secondary prevention of acute myocardial infarction (SEPAT) - guidelines adherence and outcome.
    Ergatoudes C; Thunström E; Rosengren A; Björck L; Bengtsson Boström K; Falk K; Fu M
    BMC Cardiovasc Disord; 2016 Nov; 16(1):226. PubMed ID: 27855640
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Trends and variations in the prescribing of secondary preventative cardiovascular therapies for non-ST elevation myocardial infarction (NSTEMI) in Malaysia.
    Venkatason P; Zaharan NL; Ismail MD; Wan Ahmad WA; Mahmood Zuhdi AS
    Eur J Clin Pharmacol; 2018 Jul; 74(7):953-960. PubMed ID: 29582106
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Systematic underutilisation of secondary preventive drugs in patients with acute coronary syndrome and reduced renal function.
    Khedri M; Szummer K; Carrero JJ; Jernberg T; Evans M; Jacobson SH; Spaak J
    Eur J Prev Cardiol; 2017 May; 24(7):724-734. PubMed ID: 28195517
    [TBL] [Abstract][Full Text] [Related]  

  • 111. [Secondary prevention of acute coronary syndromes: are we following correctly the guidelines?].
    Casella G; Greco C; Maggioni AP; Di Pasquale G
    G Ital Cardiol (Rome); 2006 Mar; 7(3):176-85. PubMed ID: 16572983
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Acute coronary syndromes complicated by symptomatic and asymptomatic heart failure: does current treatment comply with guidelines?
    Haim M; Battler A; Behar S; Fioretti PM; Boyko V; Simoons ML; Hasdai D
    Am Heart J; 2004 May; 147(5):859-64. PubMed ID: 15131543
    [TBL] [Abstract][Full Text] [Related]  

  • 113. A multicentre retrospective study to understand anti-platelet treatment patterns and outcomes of acute coronary syndrome patients in India (TRACE).
    Kaul U; Sethi KK; Dalal J; Parikh K; Hiremath MS; Mullasari AS; Nair T; Sandhu PS; Kotak B
    Indian Heart J; 2014; 66(3):334-9. PubMed ID: 24973840
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Association of increasing age with receipt of specialist care and long-term mortality in patients with non-ST elevation myocardial infarction.
    Zaman MJ; Fleetcroft R; Bachmann M; Sarev T; Stirling S; Clark A; Myint PK
    Age Ageing; 2016 Jan; 45(1):96-103. PubMed ID: 26601697
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Treatment practices and lipid profile of patients with acute coronary syndrome: results from a tertiary care hospital.
    Farmakis I; Zafeiropoulos S; Kartas A; Boulmpou A; Nevras V; Papadimitriou I; Tampaki A; Vlachou A; Markidis E; Koutsakis A; Ziakas A; Karvounis H; Giannakoulas G
    Acta Cardiol; 2020 Oct; 75(6):527-534. PubMed ID: 31219734
    [No Abstract]   [Full Text] [Related]  

  • 116. Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes.
    Gencer B; Rodondi N; Auer R; Räber L; Klingenberg R; Nanchen D; Carballo D; Vogt P; Carballo S; Meyer P; Matter CM; Windecker S; Lüscher TF; Mach F
    Eur J Intern Med; 2015 Jan; 26(1):56-62. PubMed ID: 25582072
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Management of acute coronary syndrome in a tertiary care general medical unit in Sri Lanka: how closely do we follow the guidelines?
    Rajapakse S; Rodrigo PC; Selvachandran J
    J Clin Pharm Ther; 2010 Aug; 35(4):421-7. PubMed ID: 20853550
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Short-term outcome and attainment of secondary prevention goals in patients with acute coronary syndrome--results from the countrywide TARGET study.
    Andrikopoulos G; Tzeis S; Nikas N; Richter D; Pipilis A; Gotsis A; Tsaknakis T; Kartalis A; Kitsiou A; Toli K; Mantas I; Olympios C; Pras A; Lampropoulos S; Oikonomou K; Pappas C; Kranidis A; Anastasiou-Nana M; Triposkiadis F; Goudevenos I; Theodorakis G; Vardas P
    Int J Cardiol; 2013 Sep; 168(2):922-7. PubMed ID: 23186596
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Management, characteristics and outcomes of patients with acute coronary syndrome in Sri Lanka.
    Galappatthy P; Bataduwaarachchi VR; Ranasinghe P; Galappatthy GKS; Wijayabandara M; Warapitiya DS; Sivapathasundaram M; Wickramarathna T; Senarath U; Sridharan S; Wijeyaratne CN; Ekanayaka R
    Heart; 2018 Sep; 104(17):1424-1431. PubMed ID: 29453329
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Use of Guideline-Directed Medical Therapy in Patients With ST-Elevation Myocardial Infarction.
    Latifi AN; Akram A; Dengle S; Minhas A; Borz-Baba C
    Cureus; 2020 Jul; 12(7):e9398. PubMed ID: 32864229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.